Ongoing monitoring includes TSH assessment 68 weeks after starting weight loss injections or dose changes, then every 612 months if stable, with levothyroxine adjustment as needed
Clinical data previously indicated that beyond lowering blood sugar and reducing weight, GLP-1 appeared to offer additional benefits that could not be explained at that time could one of them be anti-ageing
According to the SmPC, these include: Nausea usually mild to moderate and often diminishing over time Vomiting and diarrhoea which can contribute to dehydration if not managed appropriately Abdominal pain and decreased appetite reflecting the medication's effect on gastric emptying and satiety signals Constipation affecting some patients, particularly those with reduced food and fluid intake Severe gastrointestinal symptoms can lead to dehydration, which may precipitate acute kidney injury in some patients
Complementary, Not Standalone: BPC-157 should never replace fundamental recovery principles: proper nutrition, adequate sleep, appropriate training, and professional guidance
Um, but, there is Russian Roulette and, uh, Russian Roulette is taking pills that have a substantial and to some extent not fully quantified risk when the benefits are cosmetic
Sobo GLP-1 Weight Loss and Muscle Loss